DURHAM, N.C., Sept. 26, 2024 — Looma, a leading provider of in-store digital media, announced today that it has raised approximately $10 million from a group of family offices, YETI Capital, and current investors. Looma will use the funds to expand its platform in new and existing retail partners and extend its product offering.

A series of rollouts slated for 2024 and 2025 will deepen Looma’s penetration within the adult beverage category and expand their platform into all major areas of the grocery store. These rollouts grow Looma’s install base from approximately 800 screens in 2023 to over 5,000 screens by the end of 2024.

The expanded platform will feature a blend of three screen types (pictured below): Looma’s existing “high-value space screens”, along with two new screen types, “in-aisle interactives” and “atmospheric screens.”

“This capital enables us to grow a truly end-to-end, enterprise-grade in-store digital media platform, ” said Cole Johnson, Looma’s Founder & CEO. “We’re grateful to have the continued support from our existing investors and thrilled to welcome YETI Capital and our other new investors.”

In connection with the round, Margot Fooshee, former marketing executive from J.Crew and Beautycounter, joined Looma’s board of directors.

“We are fired up about partnering with the Looma team,” said Maxx Karr, Partner at YETI Capital. “They’ve built and honed the leading digital media platform over the past 8+ years, delivering meaningful performance enhancement to retail and brand partners over that time, and the company is primed to continue expansion with more national retailers & brands.”

Looma is currently deployed in 675 stores across the East Coast, Midwest, and Texas, including retailers such as H-E-B, Harris Teeter, Lowes Foods, and multiple other undisclosed retailers.

About Looma 

Looma is an in-store digital media platform focused on storytelling, education, and recommendations. Their network of in-store screens helps retailers better modernize and monetize their stores, while enabling brands to tell their story directly at the point of decision. All content that airs on Looma’s network is produced or edited by Relay™, their global network of independent filmmakers, editors, and other creators who specialize in point-of-decision content.

About YETI Capital

YETI Capital is an actively engaged, highly experienced group of investors: successful founders/entrepreneurs and their partners deliver real value to our portfolio companies throughout their development.

We want to share what we’ve learned through building YETI, Nutrabolt, C4 Energy, Urnex, and other high-growth companies with passionate and visionary founders.

We make investments only when we believe we can provide real value to founders and their teams, dedicating our time to help create success for company stakeholders. We provide regular strategic advice, alongside personal mentorship, to each founder with whom we partner.

* YETI Capital is an investment vehicle created by the founders of YETI Holdings, Inc. (YETI: NYSE) (“YETI”). YETI Capital is not affiliated in any way with YETI.

SOURCE Looma

WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

TORONTO, Sept. 26, 2024 - The Curling Group (“TCG”) announced today that it has raised US$5 million in seed funding to take the sport of curling to new heights through strategic investments, innovation, and content production that will broaden the sport’s global reach. The round was led by Toronto-based venture capital firm Relay Ventures.

Co-founded by sports, media, and entertainment industry veterans Nic Sulsky and Mike Cotton, The Curling Group announced its launch in April 2024 by acquiring the Grand Slam of Curling event series from Sportsnet (Rogers Communications Inc.). The Grand Slam of Curling is the world’s only international curling event series, featuring the best men’s and women’s teams from around the world. 

In recent years, global interest in curling has risen dramatically, sparked by its popularity during the Winter Olympics and a new generation of young and charismatic international curlers. At the same time, niche sports markets are rapidly expanding, and popularity is booming thanks to the ability to engage and monetize growing fan bases through direct-to-consumer digital offerings and streaming platforms. Understanding these trends, The Curling Group is dedicated to professionalizing the sport while reimagining how curling content is created, distributed, and consumed.

The rise in curling’s popularity is reflected in the interest of pro athletes and celebrities, including former NFL star Jared Allen and current NFL stars George Kittle and TJ Hockenson, who are all a part of The Curling Group’s initial group of investors. Two-time Olympic gold medal curler John Morris and Olympic gold medal curler Jennifer Jones are also serving as strategic advisors.

The Grand Slam of Curling season begins with the HearingLife Tour Challenge on Tuesday, October 1st in Charlottetown, Prince Edward Island. This marks the first Grand Slam event under the stewardship of The Curling Group. Enhancements to the Grand Slam of Curling experience and product will be immediately noticeable, including a total rebrand. A first look at the new branding can be viewed here.

Board of Directors

Additionally, The Curling Group has unveiled its newly-created Board of Directors, whose collective expertise will guide The Curling Group moving forward:

• Maryann Turcke (Chair) – RBC Board Member, former Chief Operating Officer of the NFL, former President of Bell Media
• Nic Sulsky – Chief Executive Officer of The Curling Group, former Chief Commercial and Revenue Officer of PointsBet Canada, former President of Monkey Knife Fight
• John Albright – Managing Partner of Relay Ventures
• John Kawaja – President of G/FORE, former President of TaylorMade, former head of North American marketing for adidas, and two-time Canadian Men’s Curling Champion (1983, 1990) and World Curling Champion (1983, 1990)
• Nicole Musicco – Former Chief Investment Officer of CalPERS, former Partner at RedBird Capital

Quotes: 

Maryann Turcke:
“As the value of niche sports properties continues to rise, we are also seeing an evolution within the sports landscape on how fans choose to engage with content and on what platforms. The Curling Group is well-positioned at the forefront of this evolution, bringing together industry leaders to identify innovative ways of reaching curling’s growing global fanbase.”

Nic Sulsky: 
“Curling’s global image is long overdue for a makeover, and we’ve made it our goal at The Curling Group to provide a reimagined, elevated offering that matches the changing face of the sport. Today’s announcement will accelerate our plans to spark massive growth within the curling world, providing fans with more ways to engage with the sport through content creation and innovation, while identifying curling’s untapped monetization potential.”

John Albright:
“We’ve been investing in sports tech & media since our inception, including companies like FUN Technologies (acquired by Liberty Media), theScore (acquired by Penn National), and Playmaker (acquired by Better Collective), among many others. All of this has led us to become deep believers in the importance and value of sports content and fan engagement. The Curling Group has a rare opportunity to develop and produce sports content and engage over 100 million fans on a global scale. We are very excited to support the development of the sport and business of curling alongside the amazing team at TCG.”

John Kawaja:
“Curling has global reach and is ready to go to the ‘next level’. As a former curler who has watched the steady growth of the game over the past decades, I’m energized to be a part of curling’s next chapter by supercharging the sport for fans around the globe.”

Nicole Musicco:
“Investing in niche sports like curling can offer unique investment opportunities for those with the vision to see its untapped potential. The Curling Group has positioned itself where passion, community, and emerging trends will converge for long-term growth.”

About The Curling Group 
The Curling Group is a sports business venture dedicated to revolutionizing the sport of curling through strategic investments and a commitment to innovation and content production. In 2024, The Curling Group acquired the Grand Slam of Curling event series, including global media rights.  

About Relay Ventures
Relay Ventures, founded in 2008, is one of Canada’s leading independent VC fund managers. The Firm is presently investing out of its fifth fund which commenced in 2022. It has invested in more than 130 companies and successfully exited more than half through M&A and IPO. The Firm has a team of 20 professionals with offices in Toronto, Calgary, and San Francisco.

SOURCE The Curling Group

WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

CHICAGO, Sept. 26, 2024 — ARCH Venture Partners today announced the closing of ARCH Venture Fund XIII, a venture capital fund with more than $3 billion to support the founding and growth of early-stage biotechnology companies.

“After more than 38 years, the ARCH investment philosophy has been consistent: we bet on great science and great teams to build breakthrough companies. We believe AI and new data-driven insights into biology will help to enable a more preventive, curative and equitable healthcare system. ARCH intends to continue driving the healthcare revolution,” said ARCH co-founder and Managing Director Robert Nelsen.

ARCH founds and invests in early-stage companies that prevent, detect and cure disease. Fund XIII investments to date include ArsenalBio, Metsera, Mirador Therapeutics and Xaira Therapeutics.

“ARCH is first and foremost a company builder; we foster innovation at scale to develop new technologies and medicines as rapidly as possible,” said ARCH Managing Director Kristina Burow. “We are well-positioned to continue catalyzing the next revolutions in healthcare to benefit those who matter most: patients.”

“ARCH has a long history of identifying the top forward-looking trends in life sciences R&D and the individuals driving truly breakthrough scientific hypotheses,” said ARCH co-founder and Managing Director Keith Crandell. “We remain incredibly excited by the pace of innovation and efforts to understand disease at a deeper level.”

Fund XIII follows the $2.975 billion Fund XII announced in June 2022.

ARCH’s Managing Directors include:

About ARCH Venture Partners
ARCH Venture Partners creates and invests in groundbreaking life science and technology companies. The firm is a recognized leader in commercializing technologies developed at academic institutions, corporate research groups and national laboratories. ARCH invests primarily in companies it co-founds with leading scientists and entrepreneurs, bringing innovations in life sciences and physical sciences to market.

For more information, visit www.archventure.com. 

Contact:
Morgan Warners
FGS Global
[email protected]

SOURCE ARCH Venture Partners

WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

• Invested in Nomic Bio’s oversubscribed $42 Million Series B round
• Led PathPresenter’s $7.5M Series A financing
• Participated in PL BioScience’s €7.8 Million Series A round

NEW YORK, Sept. 26, 2024 — AVANT BIO LLC, a pioneering growth equity firm, has announced Avant Bio Fund II LP’s participation in a series of key financing rounds, reinforcing its mission to support visionary companies developing today’s cutting-edge solutions for HealthTech, Life Sciences research, and drug development. Avant Bio Fund II LP’s participation in Nomic Bio’s Series B round and its leadership positions in growth financing rounds for PathPresenter and PL BioScience underscores AVANT BIO’s commitment to advancing companies in the biotech and life sciences sectors.

“AVANT BIO was created to partner with innovative companies and accelerate their growth to speed the introduction of the next generation of therapies. We are thrilled to announce the first portfolio companies shaping our firm and the future of the HealthTech, Life Sciences research, and drug development industries. These first investments are all revenue generating companies, demonstrating the innovation and value they bring to their customers,” stated Daniella Kranjac, Founding General Partner of AVANT BIO. “We thank our Limited Partners for their tremendous support and their confidence in our team and AVANT BIO’s mandate.”

Avant Bio Fund II LP invested in Nomic Bio’s latest Series B financing, an oversubscribed round that brings the company’s total funding to $60 million. Nomic Bio, known for its groundbreaking nELISA platform’s high-throughput capability, is positioned at the forefront of protein profiling services.

PathPresenter’s $7.5 million Series A funding round was led by Avant Bio Fund II LP.  The round is expected to propel the adoption of PathPresenter’s vendor-agnostic pathology workflow solution to enhance preventative care and improve patient outcomes. PathPresenter has grown from a free online platform into the world’s largest digital pathology community, with over 50,000 users in 172 countries.

Avant Bio Fund II LP also joined PL BioScience’s €7.8 million Series A financing round to help accelerate the commercialization of their sustainable, non-animal-derived cell culture media business. 

Reinhard Vogt, Partner of AVANT BIO, commented, “With the growing global demand for cell culture media, especially tailored for cell and gene therapies, AVANT BIO will leverage its decades of experience in pricing strategy, supply chain management, and global distribution to support PL BioScience in its growth.”

About AVANT BIO:
AVANT BIO’s investment focus spans from early stage through late-stage rounds, fostering innovation and new growth in today’s developing companies. With a commitment to amplifying value and a forward-looking investment strategy, the firm is primed to unlock the full potential of the upcoming advancements in Life Sciences, TechBio, and HealthTech. AVANT BIO is led by Daniella Kranjac, a visionary woman and vanguard in the life sciences and investment landscapes.

For more information on AVANT BIO and its innovative investment initiatives, please visit www.avant.bio.

SOURCE AVANT BIO LLC

WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

NEW YORK, Sept. 26, 2024 — Welltory, the leading all-in-one personalized health and wellness app, is pleased to announce it has closed a $3 million credit line with Braavo Capital. The funding will empower Welltory to invest deeper into its strategic product and market growth to become the leader in the preventative and people-centric care categories.

Welltory already empowers people to understand their wellness data and make personalized, smarter choices for healthier living. With Braavo Capital’s support, Welltory can push the boundaries of science and technology even further, advancing its mission through new algorithms, AI innovations, and impactful research — all aimed at building an ecosystem that helps 100 million people measurably improve their health.

“We are thrilled to expand our partnership with Welltory as they continue their journey towards becoming a dominant force in the wellness space,” said Mark Loranger, CEO of Braavo Capital. “As a long-time financing partner since 2018, we have seen Welltory grow its subscription app business to over 10 million users and were eager to lead their latest round of funding. This $3 million commitment underscores our belief in the team and their vision.”

Welltory CEO Jane Smorodnikova reiterated the sentiment; “This funding from Braavo Capital is a crucial milestone in our growth strategy. With their support, we can amplify our efforts to bring cutting-edge wellness solutions to millions of users worldwide, making preventative and user-centric care accessible to all.”

About Braavo Capital

Established in 2015, Braavo Capital is the leading funding partner for the world’s most successful app businesses. Having facilitated over $1 billion in financing and supported over 8000 apps since inception, Braavo offers a range of financing products, from on-demand receivables financing to multi-million dollar bespoke credit facilities.

About Welltory

Welltory is the tech company behind the leading all-in-one wellness app, consistently ranked in the Top 50 Grossing Health & Fitness apps and featured 20 times by the App Store. With a focus on preventative, people-centered care, Welltory is revolutionizing wellness by delivering accessible, data-driven health solutions to millions worldwide. Over 65% of Welltory Premium members report better sleep, lower stress, and improved physical activity.

SOURCE Welltory; Braavo Capital

WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

SEOUL, South Korea, Sept. 25, 2024 — Mediwhale, the AI-powered health diagnostics company, announced $12 million series A2 investments. This funding leverages the momentum of their technological advancements and rapid adoption of its innovative biomarker for preventing cardiovascular disease in general hospitals and clinics.

The financing round was led by Korea Development Bank (KDB), with participation from Woori Venture Partners, IMM Investment, Mirae Asset Securities, and other investors. This investment involves both the issuance of new shares and secondary sales.

Mediwhale initially raised $2 million in Series Pre-A funding in 2021, followed by $9 million in Series A funding in 2023. The recent Series A2 investment of $12million further strengthens the company’s growth trajectory.

Mediwhale is setting a new standard of care for the early prevention of cardiovascular disease using AI-powered retina scans. The company’s flagship product, Reti-CVD, is an AI diagnostic solution that autonomously assesses future cardiovascular disease risk using an eye scan. It is a simple, radiation-free test that provides highly accurate results equivalent to the coronary artery calcium score derived from a cardiac CT scan in predicting cardiovascular risk. Since June 2023, Reti-CVD has been approved for private reimbursement in Korea and has been utilized in over 7,200 cases across 57 medical institutions as of August 2024.

With this new capital, Mediwhale will continue to enhance AI algorithms, achieve U.S. FDA approval for Reti-CVD, expand its global footprint, and develop new products to predict chronic kidney disease risk.

“Mediwhale is the first company in the world to develop and commercialize medical AI that can predict cardiovascular disease risk through a simple eye exam. The company demonstrates significant differentiation in both business performance and technological innovation. We have decided to invest actively, confident that Mediwhale will make history in AI-driven prediction of cardiovascular and metabolic diseases both domestically and globally,” said Korea Development Bank.

Kevin Choi, CEO of Mediwhale, added, “I believe that our successful fundraising, even in a frozen capital market, is largely due to our excellent technology. With our pioneering technology, developed and commercialized as a world first, we aim to lead the global market in cardiovascular and metabolic disease management. We are determined to secure FDA De Novo approval by 2025, with plans to launch our product in the United States shortly thereafter. Additionally, to maintain a competitive edge, we will significantly enhance our AI performance and expand our product pipeline to include chronic kidney disease prediction.”

About Mediwhale

Mediwhale is the AI-powered health diagnostics company that uses non-invasive retina scans to help prevent heart and kidney diseases. Mediwhale’s solution uses deep learning algorithms to detect future disease risks even before symptoms appear. Mediwhale has been dedicated to making preventative care more affordable, accessible, safe, and convenient since being founded in 2016 in South Korea.

SOURCE Mediwhale

WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

The vehicle also has an option for up to an additional $25 Million, raising the total to $75 Million.

NEW YORK, Sept. 25, 2024 — A. Walker & Co., (AWC) a minority-owned and operated, institutionally-backed investment manager, is proud to announce that its inaugural vehicle, AWC Real Estate Opportunity Partners I, LP (“REOP I”) has a total capital commitment of up to $75 Million. The vehicle has deployed $20.4 million into multiple transactions located in California, Illinois, Georgia, Maryland, and Texas. REOP I has a total of 2,450 units acquired or under development, with $352 Million valued in underlying assets and development pipeline.

AWC remains committed to its original mission, which was to provide unique capital solutions for the development and preservation of affordable housing solutions. The firm remains steadfast in supporting diverse and emerging operators and developers, as well as the communities they serve. The firm often collaborates with co-investment partners who have similar interests to deliver both financial and community support. The firm seeks to foster sustainable and inclusive growth across the industry.

REOP I primarily focuses on small- and middle-market multifamily transactions, typically with affordable housing components, and deploys capital as a co-general partner, a limited partner, preferred equity investor, and/or mezzanine lender. The vehicle provides certainty to development partners through well-structured capital, including tax-advantaged structures.

“While we’ve been working through a challenging and turbulent economic environment,” said Austin Walker, CEO and Managing Principal, “we continue to see significant pipeline activity from our network. With our additional capital commitments, we look forward to deploying additional value-add investments and counsel into this unique market. We remain committed to supporting diverse developers, delivering value to long-term investors, and to leveraging public-private partnerships to help diverse entrepreneurs develop additional affordable housing units across the country.”

In its Q2 2024 Investor Letter, AWC reaffirmed its commitment to collaborating with the development community and mission-aligned capital partners to expand its portfolio of multifamily properties, which includes a particular focus in the South and Midwest. The firm seeks to deploy capital into investments that take full advantage of both public and private incentive programs for the development of multifamily housing in the United States. It also announced the addition of Emily Tavis, SVP of Operations and Compliance.

About A. Walker & Co.
Founded in 2022, A. Walker & Co. is a minority-led investment manager with a passion for strong partnerships with emerging and diverse multifamily operators, as well as for the preservation of affordable housing in historically significant communities and neighborhoods nationwide. They are headquartered in New York, NY. 

NOTICES

Not an Offer or Solicitation
This press release has been prepared and is being furnished solely for informational purposes, and the views and statements expressed herein are those solely of A. Walker & Co. In particular, this press release is not, and is not intended to be, an offer to sell, or a solicitation of an offer to purchase, any securities or any other interest in A. Walker & Co., REOP I, or in any fund, account, or other investment product or assets managed by A. Walker & Co., or to offer any services. Any such offering and sale would be made only on the basis of certain transaction documents and, as the case may be, a final private placement memorandum and related governing and subscription documents (together, “transaction documents”) pertaining to such offering and sale and is qualified in all respects and in its entirety by any such final transaction documents.

Valuation
The current values set forth herein include unrealized investments and are based on AWC’s estimates of fair value of such investments, and they have not been audited or independently verified by any third party. In many circumstances, a different valuation methodology would result in a different valuation and, in certain circumstances, this difference could be material. An estimate of fair value depends on subjective inputs and assumptions. Although AWC believes its fair value methodologies are appropriate, ultimate realization of the value of an asset depends to a great extent on economic and other conditions beyond the control of AWC. Actual realized returns on unrealized investments will depend on, among other factors, future operating results, the value of the assets and market conditions at the time of disposition, any related transaction costs and the timing and manner of sale or repayment, all of which may differ from the assumptions and circumstances on which the valuations used in the performance data contained herein are based. Accordingly, due to various risks, uncertainties and changes beyond the control of AWC, the actual realized returns on these unrealized investments may differ materially from the returns indicated herein and there can be no assurance that these values will ultimately be realized upon disposition of investments.

Forward-Looking Statements
Certain information contained herein constitutes “forward‐looking statements,” which can be identified by use of forward‐looking terminology such as “may,” “will,” “should,” “expect,” “attempt,” “anticipate,” “project,” “estimate,” “intend,” “seek,” “target,” “continue,” or “believe,” or the negatives thereof or other variations thereon or comparable terminology. Due to the various risks and uncertainties, actual events or results in the actual performance of investments may differ materially from those reflected or contemplated in such forward‐looking statements.

SOURCE A. Walker & Co.

WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

Biohacking Legend Dave Asprey and Solidcore Founder Anne Mahlum join investor team as company unveils new cutting-edge Artificial Intelligence

DALLAS, Sept. 25, 2024 — OxeFit, leaders of AI-driven health and fitness experiences, today announced Dave Asprey and Anne Mahlum as investors in the company’s latest $17.5M round of funding, bringing the total to over $70M, to date. With continued interest from entrepreneur and professional athlete investors, the new funds will be used to further deliver on OxeFit’s commitment to bring state-of-the-art Artificial Intelligence (AI) to its health and fitness experiences.

Anne and Dave join a deep bench of notable investors who have turned to OxeFit to achieve their own personal health and fitness goals, including soccer legend Harry Kane, pro golfer Dustin Johnson and NFL quarterback Dak Prescott.

Anchored by products (XP1 and XS1) that enable an ecosystem of deep data, the OxeFit experience includes the most technologically-advanced platforms, innovative health and wellness programs, gamification, and a robust content library that allows anyone to live healthier.

“Technology has unleashed an incredible amount of data that we can use to better ourselves mentally and physically. OxeFit’s XP1 and XS1 cracked the code on delivering the tools you need to do exactly what your body needs to become healthier and more powerful, in very little time. It’s so much more than just a gym,” said entrepreneur, author and recognized “father of biohacking,” Dave Asprey. “That’s why I’m thrilled to have added OxeFit to over 30 locations of Upgrade Labs, and I’m even more thrilled to join the OxeFit team. Together, we will transform the way we workout and live healthier, longer lives with science!”

“I look at a lot of investments and OxeFit won this category for me with a product that is head and shoulders above the competition and a talented team who knows how to execute.” said Solidcore founder Anne Mahlum. “I am incredibly excited to be part of this company that is changing the future of fitness with personalized data to help people achieve their health and wellness goals.” 

The OxeFit Experience with AI
AI is playing a pivotal role in the future of fitness. OxeFit’s core technology (hardware and software) integrates AI, robotics, movement and performance tracking, advanced coaching and analytics, all driven by unparalleled data science to connect, collaborate, and ultimately transform the health of individuals.

Starting today and rolling out in the coming months, key AI features include:

• Personalized Training Programs – The AI Virtual Trainer will create programs based not only on a user’s personal goals, but update them in real time based on how the user is training. Using AI models that are based on optimized results driven methodology, the training data is constantly monitored and evaluated by OxeFit’s software to deliver the user the perfect workout.
• Health Snapshots and Tracking – The suite of assessments and data tracking use AI models to provide analysis and insights into a user’s health and wellness status and progress. The tracking will be able to detect possible injuries before they happen or determine when post-injury rehabilitation is complete.
• Digital Training Assistant – The AI-based assistant is integrated into the product platforms and in the app, from helping users discover new OxeFit content to building an “exercise playlist” based on goals and interests. While training, the assistant will provide feedback on movements and form to maximize the results of each session. If a user has questions about their numbers, the assistant can be used to help them better understand what their data means.
• AI Gaming for OxePlay – Only OxeFit has highly dynamic interactive fitness gaming. When a game is initiated, bot players – powered by AI – will play alongside the human. This way, there will always be someone to compete with regardless of game preference and skill level. Bot intelligence includes human-like strategies and the ability to chat with users during play.

“OxeFit’s XP1 and XS1 are the only products to fully integrate a user’s data from cardio, strength, balance and gaming – allowing it to be analyzed holistically – a key differentiator in providing our users with an AI-driven training experience and the personalized insights that map to their goals and abilities,” said Rab Shanableh, CEO of OxeFit. “Dave and Anne have long pioneered a data-driven approach to healthier living, and we could not be more excited to bring their expertise to OxeFit as we continue to deliver on our mission.”

For more information, follow OxeFit on Instagram, Facebook, and Twitter.

About OxeFit
OxeFit is a digital fitness and technology company that produces the XP1 and XS1, first-of-their-kind strength training systems, revolutionizing the world of connected fitness through advanced robotics and artificial intelligence. By harnessing data-driven workout programs, the XP1 and XS1’s computer-controlled weight loads allow for variable resistance training while state-of-the-art technologies capture data and monitor form to identify weaknesses and potential for injury. Included in the OxeFit ecosystem is a library of engaging content, which seeks to bring a new element of connectivity to the fitness community. OxeFit is headquartered in Plano, Texas. For more information, visit oxefit.com.

SOURCE OxeFit

WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

Leader of “skinification” of hair care continues to invest in product innovation, retail, and expanding its network of dermatology partners

NEW YORK, Sept. 25, 2024 — SEEN, the award-winning haircare brand developed by Harvard-trained Dermatologist Dr. Iris Rubin, has closed a $9 million Series A funding. This investment will accelerate SEEN’s growth as the premier science-backed, clinically-proven beauty brand, which sits at the intersection of multiple billion-dollar markets, including haircare, sensitive skin, acne, eczema, dry scalp, and hair thinning.

The round was fully subscribed, including a strong uptake from existing and new strategic investors. Participants include Mitch Rales, Co-Founder of Danaher Corporation; Somerville SPV, led by acclaimed investor Feroz Dewan; Sator Grove Holdings, a permanent capital investor; and George Mrkonic, a Board Director of Ulta Beauty, Inc. SEEN also received early funding support from renowned Harvard dermatologists and scientists, including Dr. Rox Anderson at Harvard/Massachusetts General Hospital. 

“This marks another transformative milestone for SEEN,” said Dr. Iris Rubin, Co-Founder of SEEN. “A majority of adults in the U.S. have self-described sensitive skin and over 100 million people in the U.S. suffer from acne, eczema, dry scalp, and hair shedding, which can be exacerbated by irritating, allergenic, and/or pore-clogging ingredients in hair products. Our mission is to help people feel confident being seen by providing them salon-quality hair formulations clinically proven to also be skin friendly.” 

“Our Series A funding will allow us to focus on innovation, further scale our professional sampling to 10,000 dermatology practices in 2025, and expand our retail footprint,” said Greg Maged, Co-Founder of SEEN. “We’ve had 100% compounded annual growth since our launch and consistently exceed Ulta’s sales projections for the brand.”

Pioneering the “skinification” of hair care, SEEN is bridging the gap between luxury haircare and skincare. The brand’s success stems from Dr. Rubin’s groundbreaking insight that hair products can clog pores and irritate the skin, causing acne, eczema, and other issues. After struggling for years with breakouts, Dr. Rubin identified her haircare products as the cause. Following four years of development, SEEN launched in 2019 with three core hair products and has since grown into a complete line of haircare and styling products.

“I am delighted to become an investor in SEEN and believe they are setting a new standard for performance hair care,” said investor George Mrkonic, who currently serves on the Board of Ulta Beauty, Inc. “SEEN is applying skin science to haircare, which is exactly the kind of category-defining innovation that gets Ulta excited.”

“When we invest in a brand, we look for companies with large market potential, strong margins, and a platform that creates unique consumer benefits. We also want to invest in leadership that is smart, agile, and driven by a passion for excellence,” says Mitch Rales, SEEN investor. “SEEN embodies all these qualities.” 

Widely embraced in the dermatology community, SEEN applies rigorous skin science and testing to its formulations. SEEN’s Epidermal Rebalancing Technology uses efficacious skin-friendly ingredients to develop hair and body products that deliver stronger, smoother, healthier hair and healthy-looking skin. SEEN has been issued five patents, over 7,000 5-star reviews, and over a dozen beauty awards, and holds the National Eczema Association’s Seal of Acceptance for its fragrance-free line. SEEN is available nationwide at HelloSeen.com, ULTA, Amazon, Dermstore, and SkinStore. 

About SEEN
Harvard-trained Dermatologist Dr. Iris Rubin created SEEN after repeatedly breaking out from hair products. A scientist at heart, she knew there had to be a better way to deliver beautiful hair while respecting the skin. Prior to launching SEEN, Dr. Iris Rubin was Medical Director of the Dermatologic and Vascular Laser Surgery Program at Children’s National Medical Center in Washington DC and Maryland, where she treated children with disfiguring vascular birthmarks and scars. SEEN provides financial support to laser clinics in Armenia and Vietnam, which treat children with disfiguring birthmarks and scars. SEEN is proud to be clean, vegan, cruelty-free, and formulated without clogging oils, silicones, phthalates, parabens, dyes, gluten, or formaldehyde-releasing preservatives. 

For more information, visit https://helloseen.com/

PR Contact: Foundation, [email protected]

SOURCE SEEN

WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In